Kolve, H.
19  Ergebnisse:
Personensuche X
?
2

Azole-based chemoprophylaxis of invasive fungal infections ..:

Yunus, S. ; Pieper, S. ; Kolve, H....
Journal of Antimicrobial Chemotherapy.  69 (2013)  3 - p. 815-820 , 2013
 
?
3

Monitoring of voriconazole plasma concentrations in immunoc..:

Pieper, S. ; Kolve, H. ; Gumbinger, H. G....
Journal of Antimicrobial Chemotherapy.  67 (2012)  11 - p. 2717-2724 , 2012
 
?
4

P975 Liposomal amphotericin B followed by voriconazole for ..:

Allinson, K. ; Kolve, H. ; Gumbinger, H.G....
International Journal of Antimicrobial Agents.  29 (2007)  - p. S258 , 2007
 
?
5

Antifungal Agents: In Vitro Susceptibility Testing, Pharmac..:

Groll, A. H. ; Kolve, H.
European Journal of Clinical Microbiology & Infectious Diseases.  23 (2004)  4 - p. 256-270 , 2004
 
?
6

Stability of Ultimate Motion in an Attitude Control System ..:

Kolve, H. A. ; Clark, R. N.
Journal of Spacecraft and Rockets.  13 (1976)  9 - p. 513-514 , 1976
 
?
7

Safety and outcome of treatment with voriconazole in a larg..:

Pieper, S ; Kolve, H ; Meine, T..
Ally R, Schürmann D, Kreisel W, Carosi G, Aguirrebengoa K, Dupont B, Hodges M, Troke P, Romero AJ; Esophageal Candidiasis Study Group. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis. 2001 Nov;33(9):1447-54. DOI:10.1086/322653.  , 2015
 
?
12

Safety, tolerance and outcome of treatment with liposomal a..:

Kolve, Hedwig ; Ahlke, Elvira ; Fegeler, Wolfgang...
Journal of Antimicrobial Chemotherapy.  64 (2009)  2 - p. 383-387 , 2009
 
?
13

Secondary antifungal prophylaxis in paediatric allogeneic h..:

Allinson, Katherine ; Kolve, Hedwig ; Gumbinger, Hans G....
Journal of Antimicrobial Chemotherapy.  61 (2008)  3 - p. 734-742 , 2008
 
1-15